Neuraxis (NRXS) Shares Outstanding (Weighted Average) (2022 - 2025)
Neuraxis' Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $8.6 million for Q3 2025.
- For Q3 2025, Shares Outstanding (Weighted Average) rose 26.0% year-over-year to $8.6 million; the TTM value through Sep 2025 reached $8.6 million, up 26.0%, while the annual FY2024 figure was $6.9 million, 112.74% up from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 was $8.6 million at Neuraxis, up from $7.9 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $8.6 million in Q3 2025 and bottomed at $2.0 million in Q2 2022.
- The 4-year median for Shares Outstanding (Weighted Average) is $4.9 million (2023), against an average of $4.8 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) grew 1.69% in 2023 before it surged 245.48% in 2024.
- A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $2.0 million in 2022, then soared by 62.35% to $3.3 million in 2023, then skyrocketed by 112.74% to $6.9 million in 2024, then grew by 23.85% to $8.6 million in 2025.
- Per Business Quant, the three most recent readings for NRXS's Shares Outstanding (Weighted Average) are $8.6 million (Q3 2025), $7.9 million (Q2 2025), and $7.5 million (Q1 2025).